True Scientifically well supported Certainty of evidence: moderate provisional C-FSH-10

The sea-lice drug emamectin benzoate was found in 97% of sediment samples around Scottish salmon farms and harmed seabed crustaceans, and sea lice in the Pacific have evolved resistance to it.

In short: This claim is true as an environmental finding, now replicated in Norway; it does not show harm to people who eat salmon.
Conclusion: Correct for the environment; it does not show harm to consumers.

Original statement

رصد Bloodworth الإيموكتين بنزوات (دواء قمل البحر) في 97% من رواسب القاع حول مزارع شتلاند الإسكتلندية، فيما أظهرت Bateman أنّ قمل البحر في المحيط الهادي طوّر مقاومة تجاه هذا الدواء نفسه

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

The sea-lice drug emamectin benzoate was found in 97% of sediment samples around Scottish salmon farms and harmed seabed crustaceans, and sea lice in the Pacific have evolved resistance to it.

Origin

Source status
Archive editors
Attribution
Archive editors (eltayebat.com)
Origin
https://eltayebat.com/rule/farmed-fish/
Attribution uncertainty
Archive editorial narrative and featured-study cards, written by the archive operators; study selection is the archive's, not necessarily Elawady's.
Claimed mechanism

Drug residues in sediment; resistance selection.

Claimed health effect

Ecological harm; implied human risk.

Population concerned

Environment

Geographic restriction by Elawady

none found

Scientific assessment

True – The statement is supported by robust evidence.

Certainty of evidence: moderate – Further research may still affect the assessment.

1. What was claimed?

Sea-lice drug pollution and resistance.

2. What is demonstrably correct?

Emamectin benzoate in 97% of samples and strongest negative effect on crustacean abundance (A-FSH-15); decreased EMB sensitivity in Pacific lice since 2010 (A-FSH-16).

3. What is wrong or exaggerated?

The archive attributes A-FSH-16 to 'Bateman'; the first author is Godwin SC (Bateman AW is second author). The findings are environmental; they are not evidence of harm to people eating salmon. The EU sets a maximum residue limit for emamectin of 100 µg/kg in fin fish muscle and skin (I-RES-01).

4. What remains unclear?

Consumer exposure to emamectin residues was not studied in the cited papers.

5. Which studies support it?

A-FSH-15 (emamectin benzoate in 97% of Scottish sediment samples; negative effect on crustacean abundance); A-FSH-16 (resistance sub-claim only: Pacific salmon-lice EC50 rose 5-fold in males and 16-fold in females at one farm between 2010 and 2021, with treatment failures; 34 bioassays, 11 farms).

6. Which studies contradict it?

None against the environmental findings. They do not show harm to consumers; the EU sets a maximum residue limit for emamectin in fin fish (I-RES-01).

7. What applies to Germany and Europe?

EU MRL 100 µg/kg for emamectin B1a in fin fish (I-RES-01).

8. What is known about Egypt?

Not relevant (no salmon farming).

9. What practical conclusion is appropriate?

An environmental argument; not a demonstrated food-safety hazard.

Assessment details

Rationale for certainty of evidence

Both findings are reported in peer-reviewed studies as summarised. They concern the environment and parasite resistance, not consumer health.

Source quality

Peer-reviewed field studies.

Regional transferability

Applies to salmon farming regions (Scotland, Norway, Canada, Chile).

Individual exceptions

Not applicable.

Regional scope of the claim
depends on production conditions
Last reviewed
26 October 2026 provisional

Scientific evidence in detail

Scientifically well supported – The claim agrees with consistent, high-quality evidence.

Research question: Is emamectin benzoate widespread in sediments near salmon farms, harmful to seabed crustaceans, and are Pacific sea lice resistant to it?

Research question in detail (PECO)
Population
Seabed fauna; sea lice
Intervention or exposure
Emamectin benzoate use
Comparison
Unexposed sites / earlier years
Geographic scope
Salmon-farming regions
Outcomes
  • Sediment detection
  • Crustacean abundance
  • Resistance

Study results as reported by the authors. Our assessment follows below.

What speaks for the claim?

What speaks against the claim?

No high-quality evidence against the claim was found.

What does the overall evidence say?

Editorial assessment based on the studies above – not itself a study result.

Which position is better supported?

Correct for the environment; no evidence of consumer harm.

Why some studies weigh more

Two independent field studies.

Is a causal relationship established? Probable Consistent field associations plus toxicity to crustaceans.

Remaining uncertainty

Consumer exposure (EU MRL 100 µg/kg).

Justified conclusion

True as environmental claim.

Does this depend on the country?
General biological effects
Not applicable.
Eating habits
Not applicable.
Origin of the food
Salmon farms in Scotland, Norway, Canada.
Contaminants
EMB in sediment.
National production conditions
No salmon farming in Egypt.
Legal rules
EU MRL for emamectin in fin fish.
Actual monitoring data
Not applicable.

A regional difference that changes the conclusion is not supported by robust data.

Certainty of the overall evidence (GRADE, simplified)
Main outcome
Environmental effects of EMB
Starting level
low (observational studies)
Reasons for upgrading
  • replication in two countries
Result
moderate

Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.

Search strategy

Documented literature searches for this review (search strings in the original database syntax).

DatabaseDateSearchLooking forHitsIncluded
Europe PMC26 October 2026(emamectin) AND (residue*) AND (salmon) AND (fillet OR muscle OR consumer OR food)both directions54

How deeply was this checked?

4 linked studies: 1 checked in full text (1 of them with a structured risk-of-bias assessment), 3 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.

Last scientific review: 26 October 2026

History of the verdict
  1. 25 October 2026 · Phase 1 · Initial assessment: True (moderate)
  2. 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: True (moderate)
    Replication strengthens but does not change the verdict.
    New sources: I-FSH-115

In plain language

Salmon farms treat sea lice with a drug called emamectin benzoate. A Scottish study found it in almost all seabed samples near farms, where it harmed small crustaceans. In Canada, sea lice have become resistant to it. These are real environmental problems. The studies did not examine risks to people who eat salmon.

Studies on this claim

Studies supporting the claim (3)

  • Sea-lice drug in seabed near salmon farms

    Bloodworth JW et al.. Sci Total Environ 2019 · PMID 30878944 · DOI 10.1016/j.scitotenv.2019.02.430
    Cross-sectional studycited by the Tayebat archiveabstract checked★ key study

    The drug was found in 97% of seabed samples and was linked to fewer small crustaceans.

    Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Assess drug impact on seabed life.

    How was the study done?

    Field sampling, models.

    How many people, animals or samples were studied?

    8 farms.

    What was actually found?

    Widespread; harms crustaceans.

    How large was the observed effect?

    97% detection.

    What do the results mean in everyday life?

    Environmental problem.

    What are the study's limitations?

    Observational.

    What does it say about Elawady's specific claim?

    Supports environmental claim only.

    Do the results apply to Germany and Europe?

    Moderate.

    What can explicitly not be concluded from this study?

    Human health effects.

    Scientific details →

  • Sea lice resistant to treatment (Canada)

    Godwin SC et al.. Sci Rep 2022 · PMID 35347162 · DOI 10.1038/s41598-022-07464-1
    Othercited by the Tayebat archivefull text, structured risk-of-bias assessment

    Pacific salmon lice have become much less sensitive to emamectin since 2010.

    Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Test lice resistance.

    How was the study done?

    Bioassays.

    How many people, animals or samples were studied?

    34 bioassays from 11 farms; 73 treatments (2010-2021).

    What was actually found?

    Lice needed up to 5-16 times more drug to be killed in 2021 than in 2010; after 2019, 41% of treatments left more than half of the lice.

    What do the results mean in everyday life?

    Treatment works less.

    What are the study's limitations?

    One region.

    What does it say about Elawady's specific claim?

    Supports.

    Do the results apply to Germany and Europe?

    Low.

    What can explicitly not be concluded from this study?

    Anything about drug residues in salmon or risk to consumers.

    Scientific details →

  • Sea-lice drug harms seabed life near Norwegian salmon farms

    Arnberg M et al.. Environ Sci Technol 2026 · PMID 41566218 · DOI 10.1021/acs.est.5c11181
    Cross-sectional studyindependent cross-checkabstract checked

    Emamectin benzoate was widespread in sediments and had the strongest negative effect on seabed animals, especially crustaceans.

    EMB harms seabed crustaceans in Norway as well.

    Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Map EMB and its effects.

    How was the study done?

    Field sampling and modelling.

    How many people, animals or samples were studied?

    Norwegian farm sites.

    What was actually found?

    Persistent EMB; reduced diversity.

    How large was the observed effect?

    Effects at 0.2 ng/g.

    What do the results mean in everyday life?

    An environmental problem.

    What are the study's limitations?

    No consumer data.

    What does it say about Elawady's specific claim?

    Confirms the environmental harm.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    Risk to people eating salmon.

    Scientific details →

Studies contradicting or limiting the claim (0)

No studies in this group.

Studies with mixed or unclear results (1)

  • EU limits for veterinary drug residues

    European Commission. Official Journal of the EU 2010
    Guideline / position statementindependent cross-checkabstract checked

    The EU sets residue limits (e.g. emamectin 100 µg/kg in fish) and bans some drugs such as chloramphenicol and nitrofurans.

    Does the study support the specific claim? Unclear · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Set MRLs.

    How was the study done?

    Regulation.

    What was actually found?

    MRLs and prohibitions.

    What do the results mean in everyday life?

    Residues are legally limited.

    What are the study's limitations?

    As-adopted text.

    What does it say about Elawady's specific claim?

    Context.

    Do the results apply to Germany and Europe?

    High.

    Scientific details →

Regional context

Germany / EU

EU MRL 100 µg/kg for emamectin B1a in fin fish (I-RES-01).

Egypt

Not relevant (no salmon farming).

What applies in my country?

General scientific assessment

True Correct for the environment; it does not show harm to consumers.

The following areas of food safety are relevant to this statement:

  • Pesticides and pesticide residues
  • Veterinary medicines and antibiotics
  • Hormonal growth promoters
  • Contaminants (heavy metals, PFAS, PCBs, dioxins, nitrate)
  • Pathogens (Salmonella, Campylobacter, etc.)
  • Animal husbandry and feed

Eggs · Poultry · Dairy · Fish and seafood · Red meat · Fruit and vegetables

Choose a country to see the checked information for it.

Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.

Country of residence or purchase Compare with another country

References

  1. Negative effects of the sea lice therapeutant emamectin benzoate at low concentrations on benthic communities around Scottish fish farms.. Bloodworth JW et al.. Sci Total Environ 2019 · PMID 30878944 · DOI 10.1016/j.scitotenv.2019.02.430
  2. Salmon lice in the Pacific Ocean show evidence of evolved resistance to parasiticide treatment.. Godwin SC et al.. Sci Rep 2022 · PMID 35347162 · DOI 10.1038/s41598-022-07464-1
  3. Ecological Impacts of Emamectin Benzoate, a Sea Lice Therapeutant, on Benthic Communities in the Vicinity of Norwegian Aquaculture Facilities.. Arnberg M et al.. Environ Sci Technol 2026 · PMID 41566218 · DOI 10.1021/acs.est.5c11181
  4. Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. European Commission. Official Journal of the EU 2010

← Back to overview